IPOpulse
Sign up
Back to Ticker

Sun Pharma Advanced Research Company Limited

NSE: SPARC
₹185.07
-1.89%EOD · 19 Oct
Market Cap
₹6,006 Cr
52W Range
₹289 / ₹108
Volume
392K
42.4% delivery
1Y Return
+38.1%
P/E Ratio
3.9
P/B Ratio
4.6
ROE
276.9%
Debt / Equity
41.78

Quality Score

Durability · Valuation · Momentum — objective math, not advice
B
70/100
Composite score: 40% quality, 30% valuation, 30% momentum
QualityAverage · 50
ValuationGood · 70
MomentumStrong · 95
High ROE (276.9%)
High debt load (D/E 41.8)
In confirmed uptrend (Stage 2)
Inexpensive valuation (P/E 4x)

Technical Indicators

Full analysis · objective math, not advice
Returns
1D
-1.9%
1W
+0.1%
1M
-4.2%
3M
-18.7%
6M
+25.0%
1Y
+38.1%
Weinstein Stage
Stage 2 — Advancing (uptrend)
RSI (14)
34 Neutral
Trend Template
4/7moderate
RS vs Nifty (3M)
-12.2pp
Moving Averages (price vs MA)
20-DMA
₹195
below
50-DMA
₹197
below
150-DMA
₹191
below
200-DMA
₹176
above
From 52W High
-36.0%
From 52W Low
+71.4%
Support (20D)
₹183
Resistance (20D)
₹212

Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.

News & FilingsGoogle News + BSE

News via Google News · Not verified by IPOpulse · Not investment advice

Community discussion(0)

Sign in to join the discussion.

Sign in

No comments yet — be the first to share your view.